Effectiveness of early start of direct hemoperfusion with polymyxin B-immobilized fiber columns judging from stabilization in circulatory dynamics in surgical treatment patients
Author(s) -
Yuichiro Sakamoto,
Kunihiro Mashiko,
Toru Obata,
Hisashi Matsumoto,
Yoshiaki Hara,
Noriyoshi Kutsukata,
Hiroyuki Yokota
Publication year - 2010
Publication title -
indian journal of critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 30
eISSN - 1998-359X
pISSN - 0972-5229
DOI - 10.4103/0972-5229.63032
Subject(s) - hemoperfusion , medicine , septic shock , sofa score , apache ii , sepsis , mortality rate , polymyxin b , survival rate , shock (circulatory) , surgery , anesthesia , intensive care unit , antibiotics , hemodialysis , microbiology and biotechnology , biology
Septic shock remains a major cause of multiple organ failure and is associated with a high mortality rate. In 1994, direct hemoperfusion using a polymyxin B-immobilized fiber column (PMX; Toray Industries Inc., Tokyo Japan) was developed in Japan and has since been used for the treatment of septic shock arising from endotoxemia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom